Nootropic•Research Use Only

Dihexa

Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a small molecular weight oligopeptide derived from angiotensin IV, designed as a potent cognitive enhancer and neurogenic agent. It is considered one of the most powerful nootropic compounds ever developed, showing remarkable ability to promote synaptogenesis (formation of new synapses), enhance neurite outgrowth, and facilitate neuronal repair. Dihexa crosses the blood-brain barrier efficiently and has demonstrated extraordinary improvements in cognitive function, memory consolidation, and learning capacity in preclinical models. It works through the hepatocyte growth factor (HGF) and its receptor c-Met, promoting neuroplasticity and neuronal survival. Dihexa has shown promise in treating Alzheimer disease, traumatic brain injury, stroke recovery, and age-related cognitive decline.

Mechanism of Action

Dihexa functions as an HGF/c-Met pathway agonist, binding to and activating the hepatocyte growth factor receptor (c-Met) in the brain. This activation triggers a cascade of intracellular signaling pathways including PI3K/Akt and MAPK/ERK that promote neuronal survival, neurite outgrowth, and synaptogenesis. Unlike traditional nootropics that merely enhance neurotransmitter activity, Dihexa actually creates new neuronal connections and repairs damaged brain circuits. It increases synaptic density in the hippocampus and cortex, enhances dendritic branching, and upregulates brain-derived neurotrophic factor (BDNF) expression. The compound also protects neurons from excitotoxicity and oxidative stress while promoting neurogenesis in key brain regions involved in learning and memory.

Key Benefits

Dramatically improves memory and learning (up to 10-fold in studies)
Promotes formation of new synapses (synaptogenesis)
Enhances neuroplasticity and neural repair
Crosses blood-brain barrier efficiently
Supports recovery from traumatic brain injury
May slow or reverse cognitive decline in Alzheimer disease
Improves spatial memory and pattern recognition
Enhances executive function and processing speed
Protects neurons from damage and degeneration
Increases BDNF and other neurotrophic factors

Research Protocol

Loading Phase
5-10mg daily for 7-14 days
Maintenance
1-5mg daily (3-4 days per week)
Typically administered orally or subcutaneously. Most research used 1-5mg range. Higher doses (5-10mg) for initial loading, then reduce to 1-3mg for maintenance. Cycling recommended (5 days on, 2 days off). Take in the morning to avoid sleep disruption. Effects are cumulative and may persist after stopping. Start with lowest effective dose due to potency.

Chemical Properties

FormulaC27H44N4O5
Mol. Weight504.66 g/mol

Side Effects & Risks

  • •Very limited human safety data (primarily animal studies)
  • •Potential headaches in some users
  • •Possible vivid dreams or altered sleep patterns
  • •Unknown long-term effects in humans
  • •May interact with other neurological medications
  • •Should be avoided during pregnancy/breastfeeding

Amino Acid Sequence

N-hexanoic-Tyr-Ile-(6) aminohexanoic amide
HomeLibraryResearchFavoritesToolsVisuals